WHO WE ARE

Today, men and women will return to work in plants that were once on the verge of shutting down because new product pipelines were drying up around us. And these same individuals have also felt the fear of uncertainty caused by offshore alternatives that held a false promise of better profitability. But, now it's time to turn our attention back to the discoveries and assets that are already in hand. To better protect their value, by getting them out of commercial holding patterns, and into the hands of the people who can't live without them.

Metabolic Disease is gaining strength, but if we apply our ideas and our work ethic against it, we can meet the challenge head-on. And prove that a better commercial model and manufacturing excellence can be a better way to impact the trend of this disease.

There is a better way forward. This time, instead of following our own footsteps, we'll blaze a new trail. On the shoulders of experienced leaders who know the territory, and a manufacturing capability that is unparalleled in its category.

This is your invitation. To let Akrimax lead you forward — one success, one product, one patient at a time.

WHAT WE DO

The Promise of the Next Generation

The link that connects one generation to the next is often subtle—yet always powerful. It delivers lessons learned and allows those who follow to go further, reach higher and fulfill an even greater promise. At Akrimax, this link connects us to the traditional aspects of the pharmaceutical industry that have proven to be effective in both purpose and execution. And, it also allows us to build a stronger bridge to the future where new possibilities and opportunities exist for us to serve patients, physicians and corporate partners. Our vertical integration model allows us to maintain a strategic focus on driving profitable revenue. It means we can keep the manufacturing process here at home, ensuring optimum quality and control. And, through our progressive commercialization infrastructure, we're able to offer clients unparalleled flexibility and ROI. For us, linking the best of past generations to the possibilities of those who are to come is what next-generation pharma is all about. Making tomorrow even better because of all the yesterdays that have come before.

A FOCUS ON METABOLICS

Power to the people

There are millions of patients who are facing the daily challenges of managing metabolic diseases—from diabetes to obesity to hypertension. They're looking for someone who understands where they are and who can give them the knowledge, support and therapeutic options they need to move forward with more confidence, more hope, more power. At Akrimax, we're committed to addressing this challenge head-on by building strong relationships with customers and therapeutic thought leaders who understand the issues surrounding metabolic diseases and who appreciates how collaboration returns power to patients who want a better way to manage their condition and their lives.

BUILDING PARTNERSHIPS

Pour a Cup. Have a Seat. Let's Talk.

Relationships aren't built from transactions. They evolve from conversations. From getting to know the person across the table. From trusting that you're being listened to and understood. It's the simple art of human interaction that forms the basis for the most fulfilling relationships.

At Akrimax, we take the time we need to get to know our commercialization and manufacturing partners and for them to get to know us. We talk about business development needs from both the commercialization and manufacturing perspective—and then identify solutions that will work best for all stakeholders. It's how we build trust. It's how we build longevity. And it's how we build our business and theirs.